Piramal Phytocare (Delisted) share news and announcements
BSE: 532979
Formerly Piramal Life Sciences
Last traded ₹22.70 on 10 Dec 2019
Delisted on 27 May 2020.
Piramal Phytocare board meetings
86 filed, newest first. Page 2 of 2.
Apr 2015
Feb 2015
13 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 13, 2015, inter alia, has taken the following decision: - Mr. Deepak ....
Oct 2014
10 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2014. Further the Trading Window for dealing in the securities of the Company by the Directors/Officers / Designated Employees of the Company will remain closed from 13 October, 2014 to 21st October, 2014 pursuant to clause V of Code for Prevention of Insider Trading in Securities of the Company [framed by the Company in compliance with sub-regulation 12(1) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992] .
Jul 2014
9 Jul · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2014. Further the Trading Window for dealing in the securities of the Company by the Directors/Officers / Designated Employees of the Company will remain closed from July 10, 2014 to July 18, 2014 pursuant to clause V of Code for Prevention of Insider Trading in Securities of the Company [framed by the Company in compliance with sub-regulation 12(1) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992] .
Apr 2014
Jan 2014
29 Jan · Board meeting
To consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2013.The results shall be subjected to limited review. Further, the Trading Window for dealing in the securities of the Company by the Directors/Officers / Designated Employees of the Company will remain closed from January 30, 2014 to February 07, 2014 pursuant to clause V of Code for Prevention of Insider Trading in Securities of the Company [framed by the Company in compliance with sub-regulation 12(1) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 .
Oct 2013
24 Oct · Board meeting
Board of Directors of the Company at its Meeting held on October 24, 2013 took on record resignation of Dr. Somesh Sharma who has step down as Director of the Company. The Board of Directors have placed on record their appreciation and gratitude for the invaluable contributions made by Dr. Somesh Sharma during his tenure as member of the Board.24 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 24, 2013, inter alia, has taken following decision : - Dr. Somesh ....17 Oct · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2013.
Jul 2013
23 Jul · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2013. The results shall be subject to limited review.
Apr 2013
29 Apr · Board meeting
To inter-alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013.
Jan 2013
24 Jan · Board meeting
Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31,2012.
Oct 2012
26 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2012. The results shall be subjected to limited review.
Aug 2012
6 Aug · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
May 2012
9 May · Board meeting
To inter-alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2012.
Feb 2012
Jan 2012
24 Jan · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 3rd Quarter ended December 31,2011.
Oct 2011
21 Oct · Board meeting
Company had informed the Exchange that in view of paucity of time, it was decided that the results for the quarter ended September 30, 2011 be considered at a subsequent meeting for which necessary advance intimation would be given by the Company. The Company has now informed the Exchange that a meeting of the Board of Directors of the Company will now be held on November 02, 2011 to consider and take on record the Unaudited Financial Results of the Company for the 2nd Quarter and half year ended September 30, 2011.5 Oct · Board meeting
To consider and take on record the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2011.
Jul 2011
29 Jul · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 1st Quarter ended June 30, 2011.
May 2011
6 May · Board meeting
At its meeting held on May 6, 2011, the Board considered and approved the Scheme of Arrangement between Piramal Life Sciences Limited (`PLSL') and Piramal Healthcare Limited ('PHL') (`Demerger Scheme'). Under the proposed Demerger Scheme, the New Chemical Entity (NCE) Research Unit would be transferred from PLSL to PHL with effect from April 1, 2011, which is the Appointed Date under the Demerger Scheme. The following exchange ratio has been approved: "1 [one] fully paid up equity shares of Rs. 2/- of PHL shall be issued and allotted for every 4 [four] equity shares of Rs.10 each held in PLSL". The Demerger Scheme is subject to the consent of requisite majority of shareholders and creditors of both PLSL and PHL, sanction of the High Court of Judicature at Bombay and all other regulatory approvals as may be necessary for the implementation of the Demerger Scheme.6 May · Board meeting
Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, considered and approved the Scheme of Arrangement ....4 May · Board meeting
For considering a proposal for Demerger of the New Chemical Entity (NCE) Research Unit of the Company into Piramal Healthcare Limited.
Apr 2011
21 Apr · Board meeting
To approve the audited financial results of the Company for the financial year ended on March 31, 2011.
Jan 2011
25 Jan · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 3rd Quarter ended December 31, 2010.
Oct 2010
14 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 2nd Quarter and Half Year ended September 30, 2010.
Jul 2010
22 Jul · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2010.
Apr 2010
13 Apr · Board meeting
To approve the Audited Financial Results of the Company for the Financial Year ended on March 31, 2010.
Jan 2010
4 Jan · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 3rd Quarter ended December 31, 2009.
Oct 2009
1 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 2nd quarter and half year ended September 30, 2009.
Jul 2009
6 Jul · Board meeting
Meeting on 14 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Apr 2009
16 Apr · Board meeting
To approve the Audited Financial Results of the Company for the Financial Year ended on March 31, 2009.
Jan 2009
16 Jan · Board meeting
Meeting on 27 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
10 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 2nd Quarter and Half year ended September 30, 2008.
Jul 2008
22 Jul · Board meeting
Meeting of the Committee of Directors (Financial Results) of Company will be held on July 31, 2008 to consider and take on record the unaudited Financial Results of the Company for the 1st quarter ended June 30, 2008.